17-212

E-Prescribing of Schedule II Medications (PDF)

Submitted by District 10

WHEREAS, our nation is experiencing serious societal, medical, and psychological problems
associated with abuse of prescription opioid and other DEA schedule II drugs, and

WHEREAS, the ongoing efforts have not been effective at reducing fatalities, reducing addiction,
controlling diversion, doctor shopping, or fraudulent prescriptions, and

WHEREAS, the Virginia Prescription Monitoring Program (PMP) has created an opportunity for better
control of opioid prescribing, but has not impacted diversion or abuse, and

WHEREAS, it is possible to e-prescribe schedule II medications through highly regulated and
monitored software, and

WHEREAS, requiring that all schedule II prescriptions be submitted though this software may allow for
an interface with the Virginia PMP as well as adjacent state PMP’s, and more careful
scrutiny of prescribing patterns and at risk patients, and

WHEREAS, four other states currently have required e-prescribing of schedule II medications and
have seen benefits, and

WHEREAS, it is imperative that the MSV lead any initiative that will impose some outside control of
the patient physician relationship and the practice of medicine, therefore be it

RESOLVED, that the MSV convene a taskforce comprised of physicians from a variety of practice
settings, including hospital-based, large and small group practice, solo practitioners,
specialties, and geographic settings to conceptualize how to devise and implement
electronic prescribing of schedule II medications, and be it further

RESOLVED, that this initiative be undertaken within the next 3 months with a goal to make
recommendations that can be shared and receive feedback from MSV members within 6
months, and be it further

RESOLVED, that the task force explore and consider the following topics:

  • Mandatory e prescribing for schedule 2 medications
  • Requiring a patient-physician relationship based upon a face to face clinicalencounter as defined by the health regulatory board of Virginia (or, in the case of acovering situation, clinic)
  • All electronic prescribing software approved for use in Virginia be connected to thePMP (all electronic prescribing platforms must be interoperable).
  • Interoperability with the PMP’s of Virginia’s bordering states.
  • Waivers and/or subsidization for doctors documenting financial hardship, technologychallenges and/or no local broadband service, and for those who write few scheduleII prescriptions.
  • Identifying the costs associated with implementing the process for physicians andphysician groups and how to make it affordable.
  • Guidelines on the use paper of prescriptions for specified situations and settings.
  • Appropriateness of variable prescribing limits for specific meds and/or dosing basedupon patient’s condition, type (hospice), and physician specialty and, possibly, withopioid/pain med CME requirements
  • Design methods for data collection to monitor impact and other researchconsiderations
  • Design methods to detect problem patients and physicians and consider methods forprevention and intervention when necessary, and be it further

RESOLVED, that this taskforce shall make a report to the MSV Board of Directors with a
recommended position on mandatory e-prescribing to inform the ongoing work as
established by HB 2165.
 

Add comment